Skip to main content
. 2021 Feb 22;11(2):371. doi: 10.3390/diagnostics11020371

Table 2.

Detailed presentation of both AD biomarkers and candidate biomarkers and their levels comparison between CSF, blood and saliva.

Biomarker CSF Blood/Plasma Saliva
AD specific biomarkers (Aβ and TAU) Aβ isoforms:
1-42 Inconsistency
1-40 Inconsistency Inconsistency Unchanged
1-38 Inconsistency Inconsistency No data
1-42/Aβ1-40 ratio No data
1-42/Aβ1-38 ratio No data No data
TAU
t-TAU
p-TAU
AD non-specific biomarkers
Non-Aβ and non-TAU biomarkers
Inflammation/neuroinflammation biomarkers:
TREM2 No change No data
YKL-40 No data
IP-10 Inconsistent Inconsistent No data
ICAM1 No data No data
Synaptic dysfunction biomarkers:
Neurogranin * No change No data
SNAP-25 No data No data
Synaptotagmin ↓ (limited data) No data
Secretogranin-2 No data No data
Neuronal pentraxin 1 No data No data
Neurofascin No data No data
Myelin basic protein No data No data
BACE1 No data
α-Synuclein No change No data
TDP-43 No data No data
Lactoferrin No data No data
Acetylcholinesterase No data No data
Neuronal injury biomarkers:
NFL No data
VILIP-1 No data
Iron toxicity biomarkers:
Ferritin No change No data
hFABP No change No data

↓: decreased level in AD compared to controls; ↑: increased level in AD compared to controls; TREM2, triggering receptor expressed on myeloid cells 2; YKL-40, Chitinase-3-like protein 1; IP-10, interferon-γ-induced protein 10; ICAM1, intercellular adhesion molecule 1; *, potentially high degree of AD specificity; SNAP-25, synaptosome-associated protein 25; BACE1, β-site amyloid precursor protein cleaving enzyme 1; TDP-43, transactive response DNA-binding protein 43; NFL, neurofilament light polypeptide; VILIP-1, visinin-like protein 1; hFABP, heart-type fatty acid-binding protein.